<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="31698">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01799018</url>
  </required_header>
  <id_info>
    <org_study_id>IRB#225490</org_study_id>
    <nct_id>NCT01799018</nct_id>
  </id_info>
  <brief_title>Role of Proteomics and Metallomics in Cerebral Vasospasm Following Subarachnoid Hemorrhage</brief_title>
  <official_title>Role of Proteomics and Metallomics in Cerebral Vasospasm Following Subarachnoid Hemorrhage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>State University of New York - Upstate Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>State University of New York - Upstate Medical University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the role of Proteomics and Metallomics in Cerebral
      Vasospasm following Subarachnoid Hemorrhage
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Anticipated">April 2013</completion_date>
  <primary_completion_date type="Anticipated">April 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Protein identification and concentration</measure>
    <time_frame>For the duration of CSF drainage, or until the 21st day after admission.</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Metal ion identification and concentration</measure>
    <time_frame>For the duration of CSF drainage, or until the 21st day after admission.</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Subarachnoid Hemorrhage</condition>
  <condition>Cerebral Vasospasm</condition>
  <condition>Hydrocephalus</condition>
  <arm_group>
    <arm_group_label>SAH Patients</arm_group_label>
    <description>Patients admitted with the diagnosis of aneurismal subarachnoid hemorrhage (SAH) and cerebral angiogram negative SAH who would need to have the external ventricular drain (EVD) placed for the management of hydrocephalus.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Patients</arm_group_label>
    <description>Patients with non-hemorrhagic brain pathology such as posterior fossa tumor or stroke who will have the CSF sampling for diagnostic or therapeutic purposes.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Cerebrospinal Fluid (CSF)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to University Hospital.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Non traumatic SAH documented by CT scan

          -  Patient with SAH who would need external ventricular drain (EVD) for the management
             of hydrocephalus

          -  Patients with normal pressure Hydrocephalus that require an external drain

          -  Control (non - hemorrhagic) group - CSF collected from patients with posterior fossa
             tumor or stroke with EVD in place for the management of hydrocephalus.

        Exclusion Criteria:

          -  Recent infection within last 1 month of presentation- can increase inflammatory
             markers

          -  Recent surgery or acute myocardial infarction within last 1 month  of presentation

          -  Age &gt; 89 years or &lt; 18 years
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric M Deshaies, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>SUNY Upstate Medical University - Neurosurgery</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mark R Villwock, MS</last_name>
    <phone>315-464-5502</phone>
    <email>villwocm@upstate.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>State University of New York Upstate Medical University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark R Villwock, MS</last_name>
      <phone>315-464-5502</phone>
      <email>villwocm@upstate.edu</email>
    </contact>
    <investigator>
      <last_name>Eric M Deshaies, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <lastchanged_date>February 22, 2013</lastchanged_date>
  <firstreceived_date>December 12, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Xanthine Oxidase</keyword>
  <keyword>Cerebrospinal fluid</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Hydrocephalus</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
    <mesh_term>Vasospasm, Intracranial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
